However, PCSK9 dysfunction mutations are associated with increased circulating fasting glucose concentration, body weight and an increased risk of type 2 diabetes,32, 33 suggesting that changes in LDLR levels may trigger unknown metabolic changes for peripheral cells. The gene discussed is PCSK9; the disease is type 2 diabetes mellitus.